8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Laurent Fischer
Freenome
3 followers
Dermavant Sciences
3 followers
Keros Therapeutics
1 follower
Relay Therapeutics
1 follower
Frontier Medicines
1 follower
Thermo Fisher Scientific
140 followers
Genentech
142 followers
Gilead Sciences
119 followers
Biogen
107 followers
Regeneron
87 followers
Agilent Technologies
60 followers
Discover companies